Skip to content

Effects of Daily Supplementation of 5-HTP on Body Composition

Effects of Daily Supplementation of 5-HTP on Body Composition, a Randomized Investigation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05216406
Enrollment
65
Registered
2022-01-31
Start date
2021-01-01
Completion date
2021-05-15
Last updated
2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition

Keywords

Body Composition, 5-HTP

Brief summary

The purpose of this investigation was to compare supplementation with 5-HTP to placebo on indices of body composition. A randomized trial compared a sample of 48 resistance-trained individuals taking either 100 mg of 5-hydroxytryptophan supplementation or a placebo. The investigators tested anthropometric measurements using a multi-frequency bioelectrical impedance device (InBody® 270). The primary outcome (i.e., changes in anthropometric measurements) was assessed at the first visit (pre-test-) and post-test (8 weeks). Secondary outcomes include resting heart rate, blood pressure, and dietary intake.

Interventions

DIETARY_SUPPLEMENT5-HTP

CLEANMOOD is an organic 5-Hydroxytryptophan (5-HTP) ingredient.

OTHERPlacebo

Maltodextrin capsule

Sponsors

Nova Southeastern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

All subjects and investigators were blinded.

Intervention model description

This study followed a placebo (PLA)-controlled, double-blind and parallel-group design.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy or free of disease * Minimum of 1 year of regular physical activity. Regular physical activity is defined by a minimum of 150 minutes of aerobic activity or performing muscle-strengthening exercises at least 2 days a week.

Exclusion criteria

* Physically inactive * Regularly used sleep aids of any kind * Currently taking selective serotonin reuptake inhibitors (SSRIs) and/or 5-HTP containing supplements.

Design outcomes

Primary

MeasureTime frameDescription
Body Composition8 weeksThe percentage of fat, bone, and muscle was assessed pre and post visit using multi-frequency bioelectrical impedance device (InBody® 270).

Secondary

MeasureTime frameDescription
Dietary Habits8 weeksThe mobile app MyFitnessPal was used to assess dietary intake. Subjects were instructed to log their food intake MyFitnessPal, for a minimum of 2-3 days per week during the entire study.
Blood Pressure8 weeksSystolic and diastolic blood pressure will be measured during pre and post visit using an upper arm blood pressure monitor and cuff.
Resting Heart Rate8 weeksResting heart rate will be measured pre and post visit using an upper arm blood pressure monitor and cuff.

Countries

United States

Participant flow

Participants by arm

ArmCount
5-HTP
The dietary supplement (100 mg of 5-hydroxytryptophan; CLEANMOOD™) was provided by NURA™ (Irvine, California USA). Subjects were instructed to consume one capsule daily at their convenience for 8 weeks. 5-HTP: CLEANMOOD is an organic 5-Hydroxytryptophan (5-HTP) ingredient.
31
Control
The placebo consisted of maltodextrin. Subjects were instructed to consume one capsule daily at their convenience for 8 weeks. Placebo: Maltodextrin capsule
17
Total48

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up89

Baseline characteristics

Characteristic5-HTPControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
31 Participants17 Participants48 Participants
Blood Pressure
Diastolic
72 mmHg
STANDARD_DEVIATION 10
70 mmHg
STANDARD_DEVIATION 6
71 mmHg
STANDARD_DEVIATION 4
Blood Pressure
Systolic
118 mmHg
STANDARD_DEVIATION 14
117 mmHg
STANDARD_DEVIATION 13
117.5 mmHg
STANDARD_DEVIATION 13.5
Body Composition
Body Mass
72.9 Kilograms
STANDARD_DEVIATION 13.4
69.1 Kilograms
STANDARD_DEVIATION 11.9
71 Kilograms
STANDARD_DEVIATION 12
Body Composition
Fat Mass
15.3 Kilograms
STANDARD_DEVIATION 6
12.4 Kilograms
STANDARD_DEVIATION 4.4
13.9 Kilograms
STANDARD_DEVIATION 5.2
Body Composition
Lean Body Mass
57.5 Kilograms
STANDARD_DEVIATION 13.9
57.5 Kilograms
STANDARD_DEVIATION 13.7
57.5 Kilograms
STANDARD_DEVIATION 13.8
Dietary Intake
Carbohydrate
836 Kilocalories
STANDARD_DEVIATION 452
840 Kilocalories
STANDARD_DEVIATION 424
838 Kilocalories
STANDARD_DEVIATION 438
Dietary Intake
Fat
603 Kilocalories
STANDARD_DEVIATION 288
630 Kilocalories
STANDARD_DEVIATION 234
616.5 Kilocalories
STANDARD_DEVIATION 261
Dietary Intake
Protein
468 Kilocalories
STANDARD_DEVIATION 172
548 Kilocalories
STANDARD_DEVIATION 224
508 Kilocalories
STANDARD_DEVIATION 198
Dietary Intake
Total Intake
1906 Kilocalories
STANDARD_DEVIATION 683
2022 Kilocalories
STANDARD_DEVIATION 765
1964 Kilocalories
STANDARD_DEVIATION 720
Race and Ethnicity Not Collected0 Participants
Resting Heart Rate69 Beats Per Minute (BPM)
STANDARD_DEVIATION 12
70 Beats Per Minute (BPM)
STANDARD_DEVIATION 13
69.5 Beats Per Minute (BPM)
STANDARD_DEVIATION 10
Sex: Female, Male
Female
19 Participants11 Participants30 Participants
Sex: Female, Male
Male
12 Participants6 Participants18 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 310 / 17
other
Total, other adverse events
3 / 312 / 17
serious
Total, serious adverse events
0 / 310 / 17

Outcome results

Primary

Body Composition

The percentage of fat, bone, and muscle was assessed pre and post visit using multi-frequency bioelectrical impedance device (InBody® 270).

Time frame: 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
5-HTPBody CompositionFat Mass14.6 KilogramsStandard Deviation 5.7
5-HTPBody CompositionLean Body Mass58.4 KilogramsStandard Deviation 13.9
5-HTPBody CompositionBody Mass73 KilogramsStandard Deviation 12.8
ControlBody CompositionFat Mass12.6 KilogramsStandard Deviation 4.4
ControlBody CompositionLean Body Mass57.7 KilogramsStandard Deviation 13.6
ControlBody CompositionBody Mass70.2 KilogramsStandard Deviation 12.4
Secondary

Blood Pressure

Systolic and diastolic blood pressure will be measured during pre and post visit using an upper arm blood pressure monitor and cuff.

Time frame: 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
5-HTPBlood PressureSystolic119 mmHGStandard Deviation 14
5-HTPBlood PressureDiastolic70 mmHGStandard Deviation 7
ControlBlood PressureSystolic117 mmHGStandard Deviation 16
ControlBlood PressureDiastolic67 mmHGStandard Deviation 11
Secondary

Dietary Habits

The mobile app MyFitnessPal was used to assess dietary intake. Subjects were instructed to log their food intake MyFitnessPal, for a minimum of 2-3 days per week during the entire study.

Time frame: 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
5-HTPDietary HabitsCarbohydrate796 caloriesStandard Deviation 364
5-HTPDietary HabitsProtein440 caloriesStandard Deviation 140
5-HTPDietary HabitsTotal Intake1810 caloriesStandard Deviation 650
5-HTPDietary HabitsFat576 caloriesStandard Deviation 198
ControlDietary HabitsFat684 caloriesStandard Deviation 387
ControlDietary HabitsCarbohydrate816 caloriesStandard Deviation 392
ControlDietary HabitsTotal Intake1966 caloriesStandard Deviation 826
ControlDietary HabitsProtein464 caloriesStandard Deviation 168
Secondary

Resting Heart Rate

Resting heart rate will be measured pre and post visit using an upper arm blood pressure monitor and cuff.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
5-HTPResting Heart Rate70 BPMStandard Deviation 10
ControlResting Heart Rate65 BPMStandard Deviation 7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026